Your session is about to expire
← Back to Search
Other
MILD for Lumbar Spinal Stenosis
N/A
Waitlist Available
Led By Ramsin Benyamin, MD
Research Sponsored by Vertos Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
Study Objective: To compare patient outcomes following treatment with either the MILD procedure or epidural steroid injections (ESIs) in patients with painful lumbar spinal stenosis exhibiting neurogenic claudication and having verified ligamentum flavum hypertrophy as a contributing factor.
Eligible Conditions
- Lumbar Spinal Stenosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Number of Participants Who Achieved a Clinically Significant Improvement in the Oswestry Disability Index at 12 Months
Secondary study objectives
Number of Participants Who Acheived a Clinical Significant Improvement in the Numeric Pain Rating Scale (NPRS) at 12 Months
Number of Participants Who Achieved a Clinically Significant Improvement in the Zurich Claudication Questionnaire (ZCQ) at 12 Months
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: MILDActive Control1 Intervention
The MILD procedure is an image-guided minimally-invasive lumbar decompression
Group II: Epidural Steroid Injection (ESI)Active Control1 Intervention
An epidural steroid injection (ESI) is a combination of a corticosteroid with a local anesthetic pain relief medicine.
Find a Location
Who is running the clinical trial?
Vertos Medical, Inc.Lead Sponsor
9 Previous Clinical Trials
8,560 Total Patients Enrolled
Ramsin Benyamin, MDPrincipal InvestigatorAAPM; ASIPP; ISIS; ASA
1 Previous Clinical Trials
304 Total Patients Enrolled
Peter Staats, MDPrincipal InvestigatorAAPM; ASIPP; ASA
1 Previous Clinical Trials
231 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger